pepmg_

Study summary · research use only

Single cell transcriptomics of cerebrospinal fluid cells from patients with recent-onset narcolepsy

Study · human · Journal of autoimmunity · 2024 · DOI 10.1016/j.jaut.2024.103234 · PMID 38663202

Plain-language summary

Paraphrased from the published abstract below — not a verdict on whether anything works.

This study analyzed cerebrospinal fluid (CSF) cells from human patients with recent-onset narcolepsy type 1 (NT1, twelve patients) and type 2 (NT2, two patients) using single-cell RNA sequencing (scRNAseq), compared with CSF cells from patients with multiple sclerosis, radiologically isolated syndrome, and idiopathic intracranial hypertension as controls. From 27,255 CSF cells, the authors identified 20 clusters of different cell types and reported significant differences in three CD4+ T cell clusters and one monocyte cluster between narcolepsy and multiple sclerosis patients, with over 1000 genes differentially regulated between NT1 patients and other disease groups. The most strongly upregulated genes in narcolepsy patients versus controls, the abstract reports, encoded the MTRNR2L12 and MTRNR2L8 peptides, described as homologous to the mitochondria-encoded HUMANIN peptide implicated in other neurological diseases including Alzheimer's disease.

Abstract

Narcolepsy is a rare cause of hypersomnolence and may be associated or not with cataplexy, i.e. sudden muscle weakness. These forms are designated narcolepsy-type 1 (NT1) and -type 2 (NT2), respectively. Notable characteristics of narcolepsy are that most patients carry the HLA-DQB1*06:02 allele and NT1-patients have strongly decreased levels of hypocretin-1 (synonym orexin-A) in the cerebrospinal fluid (CSF). The pathogenesis of narcolepsy is still not completely understood but the strong HLA-bias and increased frequencies of CD4+ T cells reactive to hypocretin in the peripheral blood suggest autoimmune processes in the hypothalamus. Here we analyzed the transcriptomes of CSF-cells from twelve NT1 and two NT2 patients by single cell RNAseq (scRNAseq). As controls, we used CSF cells from patients with multiple sclerosis, radiologically isolated syndrome, and idiopathic intracranial hypertension. From 27,255 CSF cells, we identified 20 clusters of different cell types and found significant differences in three CD4+ T cell and one monocyte clusters between narcolepsy and multiple sclerosis patients. Over 1000 genes were differentially regulated between patients with NT1 and other diseases. Surprisingly, the most strongly upregulated genes in narcolepsy patients as compared to controls were coding for the genome-encoded MTRNR2L12 and MTRNR2L8 peptides, which are homologous to the mitochondria-encoded HUMANIN peptide that is known playing a role in other neurological diseases including Alzheimer's disease.

Read the full study on PubMed ↗ Open-access full text ↗

pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.